Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.
Posted inNeuroscience, New Drugs, Regulatory
Lybalvi: New Drug for Schizophrenia and Bipolar I Disorder
Combination of olanzapine and samidorphan will prevent unwanted weight gain in patients.
Posted inMetabolism, New Drugs, Regulatory
Lipaglyn: World’s First Drug to Treat Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
Saroglitazar by Zydus Cadila has opened the doors to a new multi-billion dollar sector of NASH and NAFLD pharmacological treatments.